These findings confirmed that it was the second constant range of cytoplasmic domain of SDC1 that combined with FLOT1 to allow the translocation of SDC1-TGM2 complex to lysosome, then participating in the fusion process of autophagosomes and lysosomes to regulate the radioresistance of GBM cells. The gene discussed is TGM2; the disease is glioblastoma.